Biogen shares up 5% on BIIB037 results, Alzheimer's drug showed effect on cognition
December 02, 2014 at 08:39 AM EST
Biogen shares rose more than 5 percent in pre-market trading after the company reported that BIIB037 showed effects on cognition and reduced amyloid plaques in the brain.